Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
NOVABAY PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1)(5) | Fee Rate | Amount of Registration Fee(2) |
Newly Registered Securities |
Fees to Be Paid | Equity | Common stock, $0.01 par value per share(2) | 457(o) | — | — | $4,025,000.00 | 0.00014760 | $594.09 |
| | Equity | Pre-funded warrants to purchase common stock (2)(3)(4) | 457(g) | — | — | Included above | — | — |
| | Equity | Common Stock issuable upon exercise of pre-funded warrants to purchase Common Stock(2) | 457(o) | — | — | Included above | — | — |
| | Equity | Series F-1 warrants to purchase common stock(2)(3) | 457(g) | — | — | Included above | — | — |
| | Equity | Common Stock issuable upon exercise of Series F-1 Warrants to purchase Common Stock(2) | 457(o) | — | — | $4,025,000.00 | 0.00014760 | $594.09 |
| | Equity | Series F-2 warrants to purchase common stock(2)(3) | 457(g) | — | — | Included above | | |
| | Equity | Common Stock issuable upon exercise of Series F-2 Warrants to purchase Common Stock(2) | 457(o) | — | — | $4,025,000.00 | 0.00014760 | $594.09 |
Fees Previously Paid | — | — | — | — | — | — | — | — |
Carry Forward Securities |
Carry Forward Securities | — | — | — | — | | — | | |
| | Total Offering Amounts | | $12,075,000.00 | | $1,782.27 |
| | Total Fees previously Paid | | | | $1,180.80 |
| | Total Fee Offsets | | | | — |
| | New Fees Due | | | | $601.47 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
(2) | Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions. |
(3) | No separate registration fee required pursuant to Rule 457(g) under the Securities Act. |
(4) | The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants to purchase common stock (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $4,025,000. |
(5) | Includes the maximum aggregate offering price of additional shares of common stock and/or Series F-1 warrants and Series F-2 warrants that the underwriters have the option to purchase from the Registrant, if any. |
